Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Myalept (Metreleptin) Covered by Blue Cross Blue Shield in Georgia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Myalept Covered by Blue Cross Blue Shield in Georgia Myalept (metreleptin) requires prior authorization from Blue Cross Blue Shield in Georgia and must be prescribed for FDA-approved indications (generalized lipodystrophy) through the REMS program. Your fastest path to approval: (1) Ensure your endocrinologist is REMS-certified, (2) Submit
6 min read

Myths vs. Facts: Getting Cometriq (Cabozantinib) Covered by Blue Cross Blue Shield in North Carolina - Complete Prior Authorization Guide

Answer Box: Getting Cometriq Covered by Blue Cross Blue Shield in North Carolina Eligibility: Blue Cross Blue Shield of North Carolina covers Cometriq (cabozantinib capsules) as a specialty drug requiring prior authorization for FDA-approved medullary thyroid carcinoma. Fastest path: Your oncologist submits a PA through the Prime Therapeutics portal with
5 min read

Myths vs. Facts: Getting Naglazyme (galsulfase) Covered by Blue Cross Blue Shield in Georgia – Appeals, Forms & Timelines

Answer Box: Getting Naglazyme Covered by BCBS Georgia Eligibility: Confirmed MPS VI diagnosis via enzyme assay or genetic testing is required. Fastest path: Submit complete prior authorization with specialist documentation through BCBS Georgia's Clinical Criteria CC-0023 policy. First step today: Contact your prescriber to gather diagnostic reports and
6 min read

How to Get Lutathera (Lutetium Lu-177 Dotatate) Covered by Blue Cross Blue Shield in North Carolina: Complete Guide with Forms and Appeals

Answer Box: Getting Lutathera Covered by Blue Cross Blue Shield in North Carolina Blue Cross Blue Shield of North Carolina covers Lutathera (lutetium Lu-177 dotatate) for somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors when medical necessity criteria are met. Fastest path to approval: Submit prior authorization with complete documentation including SSTR-positive imaging,
5 min read

Renewing Hemgenix (etranacogene dezaparvovec) Approval with Blue Cross Blue Shield in Pennsylvania: Annual Requirements and Timeline

Answer Box: Renewing Hemgenix Coverage in Pennsylvania Hemgenix (etranacogene dezaparvovec) is a one-time gene therapy, but Blue Cross Blue Shield plans in Pennsylvania may require annual clinical documentation for outcomes monitoring and related services coverage. Start renewal submissions 60-90 days before your authorization period expires. Submit updated Factor IX levels,
7 min read

How to Get Gamifant (Emapalumab-lzsg) Covered by Blue Cross Blue Shield of Texas: Complete Guide with Forms, Appeals, and IRO Process

Answer Box: Getting Gamifant Covered in Texas Blue Cross Blue Shield of Texas requires prior authorization for Gamifant (emapalumab-lzsg), with approval based on documented primary HLH meeting HLH-2004 criteria and failure/intolerance of conventional therapy. Submit via the BCBSTX provider portal with complete HLH diagnostic workup. If denied, Texas law
5 min read